Pheochromocytomas, MEN 2A and pregnancy

A case report with review of the literature

Benzon M. Dy, Eitan Podgaetz, William Francis Young, Geoffrey B. Thompson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pheochromocytoma in pregnancy is a rare condition with an estimated incidence of one in 54,000 pregnancies. Pheochromocytoma in the setting of multiple endocrine neoplasia (MEN) type 2A develops in approximately 40% of the patients with this germline mutation. MEN 2A patients with pheochromocytoma are often asymptomatic compared to those with nonsyndromic pheochromocytoma. We present a 28-year-old pregnant woman with a known MEN 2A mutation who was incidentally found to have a pheochromocytoma. She underwent an uncomplicated laparoscopic right adrenalectomy after proper α- and β-adrenergic blockade. Her serum fractionated metanephrines normalized prior to discharge from the hospital. The remainder of her pregnancy was uneventful and she delivered a health baby at term. Pheochromocytoma in pregnancy requires careful management to assure the well being of both the mother and the fetus. In pregnancy, laparoscopic surgical removal of the pheochromocytoma is feasible with excellent results when performed in the second trimester. In late pregnancy, medical management with close monitoring of the mother and fetus is recommended until fetal maturity is achieved. In the third trimester, cesarean section followed by open adrenalectomy is the preferred operation. An integrated and multidisciplinary approach with close communication among the endocrinologist, surgeon and perinatal services is paramount to achieve excellent outcomes for both patients. Women with MEN 2 should be advised to refrain from pregnancy until updated biochemical and imaging studies have ruled out pheochromocytoma.

Original languageEnglish (US)
Pages (from-to)29-32
Number of pages4
JournalWorld Journal of Endocrine Surgery
Volume4
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Multiple Endocrine Neoplasia
Pheochromocytoma
Pregnancy
Adrenalectomy
Fetus
Mothers
Metanephrine
Multiple Endocrine Neoplasia Type 2a
Germ-Line Mutation
Third Pregnancy Trimester
Second Pregnancy Trimester
Cesarean Section
Adrenergic Agents
Pregnant Women
Communication
Mutation
Incidence

Keywords

  • MEN 2A
  • Pheochromocytoma
  • Pregnancy

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Radiology Nuclear Medicine and imaging

Cite this

Pheochromocytomas, MEN 2A and pregnancy : A case report with review of the literature. / Dy, Benzon M.; Podgaetz, Eitan; Young, William Francis; Thompson, Geoffrey B.

In: World Journal of Endocrine Surgery, Vol. 4, No. 1, 01.2012, p. 29-32.

Research output: Contribution to journalArticle

Dy, Benzon M. ; Podgaetz, Eitan ; Young, William Francis ; Thompson, Geoffrey B. / Pheochromocytomas, MEN 2A and pregnancy : A case report with review of the literature. In: World Journal of Endocrine Surgery. 2012 ; Vol. 4, No. 1. pp. 29-32.
@article{74130dd1f93642d4b4701f52d21e4580,
title = "Pheochromocytomas, MEN 2A and pregnancy: A case report with review of the literature",
abstract = "Pheochromocytoma in pregnancy is a rare condition with an estimated incidence of one in 54,000 pregnancies. Pheochromocytoma in the setting of multiple endocrine neoplasia (MEN) type 2A develops in approximately 40{\%} of the patients with this germline mutation. MEN 2A patients with pheochromocytoma are often asymptomatic compared to those with nonsyndromic pheochromocytoma. We present a 28-year-old pregnant woman with a known MEN 2A mutation who was incidentally found to have a pheochromocytoma. She underwent an uncomplicated laparoscopic right adrenalectomy after proper α- and β-adrenergic blockade. Her serum fractionated metanephrines normalized prior to discharge from the hospital. The remainder of her pregnancy was uneventful and she delivered a health baby at term. Pheochromocytoma in pregnancy requires careful management to assure the well being of both the mother and the fetus. In pregnancy, laparoscopic surgical removal of the pheochromocytoma is feasible with excellent results when performed in the second trimester. In late pregnancy, medical management with close monitoring of the mother and fetus is recommended until fetal maturity is achieved. In the third trimester, cesarean section followed by open adrenalectomy is the preferred operation. An integrated and multidisciplinary approach with close communication among the endocrinologist, surgeon and perinatal services is paramount to achieve excellent outcomes for both patients. Women with MEN 2 should be advised to refrain from pregnancy until updated biochemical and imaging studies have ruled out pheochromocytoma.",
keywords = "MEN 2A, Pheochromocytoma, Pregnancy",
author = "Dy, {Benzon M.} and Eitan Podgaetz and Young, {William Francis} and Thompson, {Geoffrey B.}",
year = "2012",
month = "1",
doi = "10.5005/jp-journals-10002-1090",
language = "English (US)",
volume = "4",
pages = "29--32",
journal = "World Journal of Endocrine Surgery",
issn = "0975-5039",
publisher = "Jaypee Brothers Medical Publishers (P) Ltd",
number = "1",

}

TY - JOUR

T1 - Pheochromocytomas, MEN 2A and pregnancy

T2 - A case report with review of the literature

AU - Dy, Benzon M.

AU - Podgaetz, Eitan

AU - Young, William Francis

AU - Thompson, Geoffrey B.

PY - 2012/1

Y1 - 2012/1

N2 - Pheochromocytoma in pregnancy is a rare condition with an estimated incidence of one in 54,000 pregnancies. Pheochromocytoma in the setting of multiple endocrine neoplasia (MEN) type 2A develops in approximately 40% of the patients with this germline mutation. MEN 2A patients with pheochromocytoma are often asymptomatic compared to those with nonsyndromic pheochromocytoma. We present a 28-year-old pregnant woman with a known MEN 2A mutation who was incidentally found to have a pheochromocytoma. She underwent an uncomplicated laparoscopic right adrenalectomy after proper α- and β-adrenergic blockade. Her serum fractionated metanephrines normalized prior to discharge from the hospital. The remainder of her pregnancy was uneventful and she delivered a health baby at term. Pheochromocytoma in pregnancy requires careful management to assure the well being of both the mother and the fetus. In pregnancy, laparoscopic surgical removal of the pheochromocytoma is feasible with excellent results when performed in the second trimester. In late pregnancy, medical management with close monitoring of the mother and fetus is recommended until fetal maturity is achieved. In the third trimester, cesarean section followed by open adrenalectomy is the preferred operation. An integrated and multidisciplinary approach with close communication among the endocrinologist, surgeon and perinatal services is paramount to achieve excellent outcomes for both patients. Women with MEN 2 should be advised to refrain from pregnancy until updated biochemical and imaging studies have ruled out pheochromocytoma.

AB - Pheochromocytoma in pregnancy is a rare condition with an estimated incidence of one in 54,000 pregnancies. Pheochromocytoma in the setting of multiple endocrine neoplasia (MEN) type 2A develops in approximately 40% of the patients with this germline mutation. MEN 2A patients with pheochromocytoma are often asymptomatic compared to those with nonsyndromic pheochromocytoma. We present a 28-year-old pregnant woman with a known MEN 2A mutation who was incidentally found to have a pheochromocytoma. She underwent an uncomplicated laparoscopic right adrenalectomy after proper α- and β-adrenergic blockade. Her serum fractionated metanephrines normalized prior to discharge from the hospital. The remainder of her pregnancy was uneventful and she delivered a health baby at term. Pheochromocytoma in pregnancy requires careful management to assure the well being of both the mother and the fetus. In pregnancy, laparoscopic surgical removal of the pheochromocytoma is feasible with excellent results when performed in the second trimester. In late pregnancy, medical management with close monitoring of the mother and fetus is recommended until fetal maturity is achieved. In the third trimester, cesarean section followed by open adrenalectomy is the preferred operation. An integrated and multidisciplinary approach with close communication among the endocrinologist, surgeon and perinatal services is paramount to achieve excellent outcomes for both patients. Women with MEN 2 should be advised to refrain from pregnancy until updated biochemical and imaging studies have ruled out pheochromocytoma.

KW - MEN 2A

KW - Pheochromocytoma

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84860346282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860346282&partnerID=8YFLogxK

U2 - 10.5005/jp-journals-10002-1090

DO - 10.5005/jp-journals-10002-1090

M3 - Article

VL - 4

SP - 29

EP - 32

JO - World Journal of Endocrine Surgery

JF - World Journal of Endocrine Surgery

SN - 0975-5039

IS - 1

ER -